Kezar Life Sciences Stock (NASDAQ: KZR) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 795.928K |
Day Range | - - - |
52 Wk Range | 0.675 - 3.130 |
Market Cap | $53.851M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 36 |
Short Interest | 5.37% |
Days to Cover | 5 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Kezar Life Sciences (NASDAQ: KZR) through any online brokerage.
Other companies in Kezar Life Sciences’s space includes: CARISMA Therapeutics (NASDAQ:CARM), Intensity Therapeutics (NASDAQ:INTS), Eagle Pharmaceuticals (NASDAQ:EGRX), Immuneering (NASDAQ:IMRX) and Aligos Therapeutics (NASDAQ:ALGS).
The latest price target for Kezar Life Sciences (NASDAQ: KZR) was reported by HC Wainwright & Co. on Friday, May 10, 2024. The analyst firm set a price target for 20.00 expecting KZR to rise to within 12 months (a possible 2603.80% upside). 10 analyst firms have reported ratings in the last year.
The stock price for Kezar Life Sciences (NASDAQ: KZR) is $0.7397 last updated May 13, 2024 at 7:56 PM EDT.
There are no upcoming dividends for Kezar Life Sciences.
Kezar Life Sciences’s Q2 earnings are confirmed for Thursday, August 8, 2024.
There is no upcoming split for Kezar Life Sciences.
Kezar Life Sciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.